GABA Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $500K

  • Investors
  • 2

GABA Therapeutics General Information

Description

Developer of a medicinal compound designed to be used in the treatment of anxiety, depression, and a broad range of neurological disorders. The company's medication has the same rapid onset and efficacy as benzodiazepines but with minimal to no side effects, enabling patients with life-altering neuropsychiatric, neurologic, and pain disorders.

Contact Information

Website
www.gabarx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5000 Birch Street
  • West Tower, Suite 3000
  • Newport Beach, CA 92660
  • United States
+1 (855)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 5000 Birch Street
  • West Tower, Suite 3000
  • Newport Beach, CA 92660
  • United States
+1 (855)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GABA Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 11-Oct-2023 $500K Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 17-Oct-2019 Completed Clinical Trials - Phase 2
To view GABA Therapeutics’s complete valuation and funding history, request access »

GABA Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view GABA Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

GABA Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medicinal compound designed to be used in the treatment of anxiety, depression, and a broad range of neur
Drug Discovery
Newport Beach, CA
6 As of 2023

La Jolla, CA
 

Radnor, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GABA Therapeutics Competitors (2)

One of GABA Therapeutics’s 2 competitors is MediciNova, a Formerly VC-backed company based in La Jolla, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MediciNova Formerly VC-backed La Jolla, CA
Marinus Pharmaceuticals Private Equity-Backed Radnor, PA
You’re viewing 2 of 2 competitors. Get the full list »

GABA Therapeutics Patents

GABA Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026226907-A1 Stable oral solid formulation of deuterated etifoxine hcl, derivatives and uses thereof Pending 24-Apr-2025
AU-2023367693-A1 Deuterated analogs of etifoxine and methods of administration without autoinduction of metabolism Pending 24-Oct-2022
EP-4608408-A2 Deuterated analogs of etifoxine and methods of administration without autoinduction of metabolism Pending 24-Oct-2022
EP-4608408-A4 Deuterated analogs of etifoxine and methods of administration without autoinduction of metabolism Pending 24-Oct-2022
US-20240189316-A1 Deuterated analogs of etifoxine and methods of administration without autoinduction of metabolism Pending 24-Oct-2022 A61K31/536
To view GABA Therapeutics’s complete patent history, request access »

GABA Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GABA Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Robin Hood Ventures Angel Group Minority
AtaiBeckley Corporation Minority
To view GABA Therapeutics’s complete investors history, request access »

GABA Therapeutics FAQs

  • When was GABA Therapeutics founded?

    GABA Therapeutics was founded in 2018.

  • Where is GABA Therapeutics headquartered?

    GABA Therapeutics is headquartered in Newport Beach, CA.

  • What is the size of GABA Therapeutics?

    GABA Therapeutics has 6 total employees.

  • What industry is GABA Therapeutics in?

    GABA Therapeutics’s primary industry is Drug Discovery.

  • Is GABA Therapeutics a private or public company?

    GABA Therapeutics is a Private company.

  • What is GABA Therapeutics’s current revenue?

    The current revenue for GABA Therapeutics is .

  • How much funding has GABA Therapeutics raised over time?

    GABA Therapeutics has raised $22M.

  • Who are GABA Therapeutics’s investors?

    Robin Hood Ventures and AtaiBeckley have invested in GABA Therapeutics.

  • Who are GABA Therapeutics’s competitors?

    MediciNova and Marinus Pharmaceuticals are competitors of GABA Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process